Medical Device Postmarketing Vigilance Reporting

9 November 2010
San Diego, California, US

Seminar topics include new terms and definitions, the extended scope of a revised medical device guidance document on postmarketing vigilance (MEDDEV 2.12-1 rev 5) that came into force on 1 January 2008, reporting criteria and timelines, filing safety notices and field safety corrective actions, and more

Organiser: Barnett Educational Services

Email this story